BIOAF biOasis Technologies Inc

USD 0.00 0.00 0
Icon

biOasis Technologies Inc (BIOAF) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.004

0.00 (0.00)%

USD 0.32M

N/A

N/A

N/A

Icon

BIOAF

biOasis Technologies Inc (USD)
COMMON STOCK | OTC
USD 0.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.32M

N/A

USD 0.00

biOasis Technologies Inc (BIOAF) Stock Forecast

N/A

Based on the biOasis Technologies Inc stock forecast from 0 analysts, the average analyst target price for biOasis Technologies Inc is not available over the next 12 months. biOasis Technologies Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of biOasis Technologies Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, biOasis Technologies Inc’s stock price was USD 0.004. biOasis Technologies Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -60.00% over the last year.

No recent analyst target price found for biOasis Technologies Inc
No recent average analyst rating found for biOasis Technologies Inc

Company Overview biOasis Technologies Inc

Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agent...Read More

https://www.bioasis.us

157 Church Street, New Haven, CT, United States, 06510

0

February

USD

USA

Adjusted Closing Price for biOasis Technologies Inc (BIOAF)

Loading...

Unadjusted Closing Price for biOasis Technologies Inc (BIOAF)

Loading...

Share Trading Volume for biOasis Technologies Inc Shares

Loading...

Compare Performance of biOasis Technologies Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIOAF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To biOasis Technologies Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NONOF
Novo Nordisk A/S 0.00 (0.00%) USD599.53B 46.79 4.92

ETFs Containing BIOAF

Symbol Name BIOAF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About biOasis Technologies Inc (BIOAF) Stock

Stock Target Advisor's fundamental analysis for biOasis Technologies Inc's stock is Bearish.

Unfortunately we do not have enough data on BIOAF's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BIOAF's stock to indicate what its average analyst target is.

BIOAF stock's Price/Earning ratio is 25.56. Our analysis grades BIOAF stock's Price / Earning ratio at F. This means that BIOAF stock's Price/Earning ratio is above 61% of the stocks in the Biotechnology sector in the OTC exchange. Based on this BIOAF may be a overvalued for its sector.

The last closing price of BIOAF's stock was USD 0.00.

The most recent market capitalization for BIOAF is USD 0.32M.

Unfortunately we do not have enough analyst data on BIOAF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains biOasis Technologies Inc's stock.

As per our most recent records biOasis Technologies Inc has 0 Employees.

biOasis Technologies Inc's registered address is 157 Church Street, New Haven, CT, United States, 06510. You can get more information about it from biOasis Technologies Inc's website at https://www.bioasis.us.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...